Registration Dossier

Administrative data

Description of key information

Hypergastrinemia is shown due to significant elevations in serum gastrin have been reported. Moreover, other adverse effects are reported by epidemiological data such as effects on the endocrine system and neuropsychiatric symptoms. Finally, it is probably porphyrinogenic.

Additional information

Epidemiological data report effects on gastrointestinal tract and other multiple effects system. For these reasons, according to Directive 67/548/EEC and to Regulation (EC) n. 1272/2008, the substance should be classified for specific target organ toxicity after repeated exposure.